Correspondence 0001493152-22-034886 from Advaxis, Inc. (ADXS) (CIK 0001100397)

Advaxis, Inc. (ADXS) (CIK 0001100397)
Date: Dec. 8, 2022 · CIK: 0001100397 · Accession: 0001493152-22-034886

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-268586

Date

Dec. 8, 2022

Author

President

Form

CORRESP

Company

Advaxis, Inc. (ADXS) (CIK 0001100397)

Letter

Division of Corporate Finance Office of Life Sciences Attention: Alan Campbell VIA EDGAR Re: Advaxis, Inc. Registration Statement on Form S-4 Filed November 29, 2022 File No. 333-268586

Dear Mr. Campbell:

In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of Amendment No. 1 to the Registration Statement on Form S-4 (File No. 333-268586) (the “Registration Statement”) of Advaxis, Inc. We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern time, on December 12, 2022, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Justin W. Chairman at (215) 963-5061 or Emily Drazan Chapman at (202) 739-5699.

Very
Truly Yours,
Advaxis,
Inc.

Show Raw Text

CORRESP
1
filename1.htm

Advaxis,
Inc.

9
Deer Park Drive, Suite K-1

Monmouth
Junction, NJ 08852

December
8, 2022

U.S.
Securities and Exchange Commission

Division
of Corporate Finance

Office
of Life Sciences

100
F Street NE

Washington,
DC 20549

Attention:
Alan Campbell

VIA
EDGAR

    Re:
    Advaxis,
    Inc.

    Registration
    Statement on Form S-4

    Filed
    November 29, 2022

    File
    No. 333-268586

Dear
Mr. Campbell:

In
accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby
request acceleration of the effective date of Amendment No. 1 to the Registration Statement on Form S-4 (File No. 333-268586) (the “Registration
Statement”) of Advaxis, Inc. We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern
time, on December 12, 2022, or as soon as practicable thereafter. Once the Registration Statement has been declared effective,
please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Justin W. Chairman at (215) 963-5061 or
Emily Drazan Chapman at (202) 739-5699.

    Very
    Truly Yours,

    Advaxis,
    Inc.

    By:

    /s/
    Kenneth A. Berlin

    Name:
    Kenneth
    A. Berlin

    Title:

    President
    and Chief Executive Officer

    cc:

    Morgan,
    Lewis & Bockius LLP

SecProbe.io